FDA proposes constraints on ephedrine dietary supplements

被引：0

|

作者：

不详

机构：

来源：

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 1997年 / 54卷 / 14期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：1578 / 1578

页数：1

相关论文

共 50 条

[31] FDA proposes xenotransplant guidelines
Cimons, M
ASM NEWS, 1996, 62 (12): : 624 - 626
[32] FDA proposes GMP revisions
不详
BIOPHARM INTERNATIONAL, 2008, 21 (01) : 10 - 10
[33] FDA proposes lab closures
不详
CHEMICAL & ENGINEERING NEWS, 2007, 85 (01) : 18 - 18
[34] FDA proposes CGMP revisions
不详
CHEMICAL ENGINEERING PROGRESS, 2008, 104 (01) : 10 - 12
[35] Determination of ephedrine alkaloids in botanicals and dietary supplements by HPLC-UV: Collaborative study
Roman, MC
Walther, HJ
JOURNAL OF AOAC INTERNATIONAL, 2004, 87 (01) : 1 - 14
[36] Separation and determination of ephedrine enantiomers and synephrine by high performance capillary electrophoresis in dietary supplements
Avula, B
Khan, IA
CHROMATOGRAPHIA, 2004, 59 (1-2) : 71 - 77
[37] Separation and Determination of Ephedrine Enantiomers and Synephrine by High Performance Capillary Electrophoresis in Dietary Supplements
B. Avula
I. A. Khan
Chromatographia, 2004, 59 : 71 - 77
[38] Harmless energizers or dangerous drugs? Government ponders ephedrine-containing dietary supplements
Palevitz, BA
SCIENTIST, 2002, 16 (24): : 18 - 20
[39] Safety concerns regarding ephedrine-type alkaloid-containing dietary supplements
Miller, SC
MILITARY MEDICINE, 2004, 169 (02) : 87 - 93
[40] Recalls, Availability, and Content of Dietary Supplements Following FDA Warning Letters
Cohen, Pieter A.
Avula, Bharathi
Katragunta, Kumar
Khan, Ikhlas
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (04): : 393 - +

← 1 2 3 4 5 →